Contribution: Industrial Research Assistance Program – Contributions to Firms
NovoBind Livestock Therapeutics Inc
$700,000.00
Development of novel feedstock additives to combat diseases in farmed shrimp - proof of concept
FY 2020-21 · 2020-09-01
Summary
Based on NovoBind's novel single-chain antibody fragment (nanobody) technology, the goal of this project is the development and in vivo proof-of-concept of engineered nanobodies to be used as a feed additive to reduce or eliminate Vibrio and White Spot Syndrome Virus infections in the gastrointestinal tract of farmed shrimp.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
843602244
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-09-01 | 2020-21 | $450,000.00 |
| 1 | 2020-09-01 | 2020-21 | $700,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 250,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 250 000 dollars.
Agreement End Date
2022-06-30
Agreement Number
958358
Agreement Start Date
2020-09-01
Agreement Title
Development of novel feedstock additives to combat diseases in farmed shrimp - proof of concept
Agreement Title (French)
Mise au point de nouveaux additifs à la matière première afin de lutter contre les maladies des crevettes d'élevage - preuve du concept
Agreement Type
Contribution
Agreement Value
$700,000.00
Amendment Date
2021-12-14
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Based on NovoBind's novel single-chain antibody fragment (nanobody) technology, the goal of this project is the development and in vivo proof-of-concept of engineered nanobodies to be used as a feed additive to reduce or eliminate Vibrio and White Spot Syndrome Virus infections in the gastrointestinal tract of farmed shrimp.
Description (French)
Basé sur la nouvelle technologie de fragments d'anticorps à chaîne unique (nanocorps) de NovoBind, le but de ce projet est le développement et la preuve de concept in vivo de nanocorps artificiels destinés à être utilisés comme additifs alimentaires pour réduire ou éliminer les infections à vibrio et au virus du syndrome des points blancs dans le tractus gastro-intestinal des crevettes d'élevage.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
115210
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
843602244
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
NovoBind Livestock Therapeutics Inc
Recipient Postal Code
V6E 0C3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q3-958358
